A box of Spravato nasal spray medication placed on a wooden table in a living room setting, with a black leather chair and a green plant in the background.
Label for Spravato (esketamine) nasal spray indicating 28 mg dosage, with colorful lines emanating from a burst on the right side.

Coming Soon

SPRAVATO®, the only FDAapproved nasal spray for adults with treatment-resistant depression (TRD), reduces depression symptoms when two or more oral antidepressants haven’t worked. SPRAVATO® can be taken with or without an oral antidepressant.